| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients
|
Decker, Yann
|
|
2016
|
|
14 |
p. 1794-1803
|
artikel
|
| 2 |
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis
|
Outteryck, Olivier
|
|
2015
|
|
14 |
p. 1781-1793
|
artikel
|
| 3 |
Age Related Multiple Sclerosis Severity Score: Disability ranked by age
|
Manouchehrinia, Ali
|
|
2017
|
|
14 |
p. 1938-1946
|
artikel
|
| 4 |
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – Commentary
|
Arrambide, Georgina
|
|
|
|
14 |
p. 1845-1847
|
artikel
|
| 5 |
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – No
|
Chard, Declan T
|
|
|
|
14 |
p. 1843-1845
|
artikel
|
| 6 |
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – Yes
|
Rojas, Juan Ignacio
|
|
|
|
14 |
p. 1842-1843
|
artikel
|
| 7 |
An epidemiological study of neuromyelitis optica in Isfahan
|
Etemadifar, Masoud
|
|
2014
|
|
14 |
p. 1920-1922
|
artikel
|
| 8 |
An overview of biosimilars and non-biologic complex drugs in Europe, the United States, and Canada and their relevance to multiple sclerosis
|
Gran-Ruaz, Sophia
|
|
2017
|
|
14 |
p. 1824-1829
|
artikel
|
| 9 |
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis
|
Kvistad, Silje
|
|
2014
|
|
14 |
p. 1833-1840
|
artikel
|
| 10 |
Anti-JC virus antibody titres increase over time with natalizumab treatment
|
Raffel, J
|
|
2015
|
|
14 |
p. 1833-1838
|
artikel
|
| 11 |
A population-based prospective study of optic neuritis
|
Soelberg, K
|
|
2017
|
|
14 |
p. 1893-1901
|
artikel
|
| 12 |
Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases
|
Zhang, Jinhua
|
|
2017
|
|
14 |
p. 1950-1954
|
artikel
|
| 13 |
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis
|
Lapshin, Helen
|
|
2013
|
|
14 |
p. 1905-1912
|
artikel
|
| 14 |
Benchmarks of meaningful impairment on the MSFC and BICAMS
|
Benedict, Ralph HB
|
|
2016
|
|
14 |
p. 1874-1882
|
artikel
|
| 15 |
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients
|
Muñoz-Culla, M
|
|
2014
|
|
14 |
p. 1851-1859
|
artikel
|
| 16 |
Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
|
Modvig, S
|
|
2015
|
|
14 |
p. 1761-1770
|
artikel
|
| 17 |
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment
|
Jensen, HB
|
|
2014
|
|
14 |
p. 1872-1880
|
artikel
|
| 18 |
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases
|
Baumann, Matthias
|
|
2016
|
|
14 |
p. 1821-1829
|
artikel
|
| 19 |
Christian Confavreux (1949 – 2013)
|
Weinshenker, Brian G
|
|
2013
|
|
14 |
p. 1811-1812
|
artikel
|
| 20 |
Clinical commentary on ‘Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases’, by Wang et al.
|
Flanagan, Eoin P
|
|
2017
|
|
14 |
p. 1954-1955
|
artikel
|
| 21 |
Clinical impact of early brain atrophy in clinically isolated syndromes
|
Pérez-Miralles, F
|
|
2013
|
|
14 |
p. 1878-1886
|
artikel
|
| 22 |
Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis
|
Kim, Su-Hyun
|
|
2016
|
|
14 |
p. 1850-1858
|
artikel
|
| 23 |
Cognitive impairment in Chinese neuromyelitis optica
|
Zhang, N
|
|
2015
|
|
14 |
p. 1839-1846
|
artikel
|
| 24 |
Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review
|
Wojcik, Curtis M
|
|
|
|
14 |
p. 1848-1869
|
artikel
|
| 25 |
Concurrent LETM and nerve root enhancement in spinal neurosarcoid: A case series
|
Deng, Pojen
|
|
2018
|
|
14 |
p. 1913-1916
|
artikel
|
| 26 |
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors
|
Pryce, G
|
|
2013
|
|
14 |
p. 1896-1904
|
artikel
|
| 27 |
Corrigendum
|
|
|
2016
|
|
14 |
p. NP13
|
artikel
|
| 28 |
Corrigendum
|
|
|
2017
|
|
14 |
p. NP1
|
artikel
|
| 29 |
Corticospinal tract integrity is related to primary motor cortex thinning in relapsing–remitting multiple sclerosis
|
Bergsland, Niels
|
|
2015
|
|
14 |
p. 1771-1780
|
artikel
|
| 30 |
CRYAB modulates the activation of CD4+ T cells from relapsing–remitting multiple sclerosis patients
|
Quach, Que Lan
|
|
2013
|
|
14 |
p. 1867-1877
|
artikel
|
| 31 |
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis
|
Fenoglio, Chiara
|
|
2013
|
|
14 |
p. 1938-1942
|
artikel
|
| 32 |
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis
|
Pender, Michael P
|
|
2014
|
|
14 |
p. 1825-1832
|
artikel
|
| 33 |
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod
|
Papathemeli, Despoina
|
|
2016
|
|
14 |
p. 1888-1890
|
artikel
|
| 34 |
Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item version
|
Luijten, Michiel AJ
|
|
2018
|
|
14 |
p. 1892-1901
|
artikel
|
| 35 |
Differential microRNA expression in blood in multiple sclerosis
|
Søndergaard, Helle Bach
|
|
2013
|
|
14 |
p. 1849-1857
|
artikel
|
| 36 |
Disease modification in advanced MS: Focus on upper limb function
|
Dubuisson, Nicolas
|
|
2017
|
|
14 |
p. 1956-1957
|
artikel
|
| 37 |
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
|
Rotondi, Mario
|
|
2014
|
|
14 |
p. 1918-1919
|
artikel
|
| 38 |
DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS
|
Preziosa, Paolo
|
|
2017
|
|
14 |
p. 1918-1928
|
artikel
|
| 39 |
Dual action by fumaric acid esters synergistically reduces adhesion to human endothelium
|
Breuer, Johanna
|
|
2018
|
|
14 |
p. 1871-1882
|
artikel
|
| 40 |
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study
|
Mancuso, R
|
|
2014
|
|
14 |
p. 1900-1903
|
artikel
|
| 41 |
Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE
|
Cohan, Stanley
|
|
2018
|
|
14 |
p. 1883-1891
|
artikel
|
| 42 |
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
|
Sepúlveda, Maria
|
|
2018
|
|
14 |
p. 1843-1851
|
artikel
|
| 43 |
Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory
|
Mokkink, Lidwine Brigitta
|
|
2016
|
|
14 |
p. 1867-1873
|
artikel
|
| 44 |
Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies
|
Gopal, Sreeja
|
|
2017
|
|
14 |
p. 1875-1883
|
artikel
|
| 45 |
Evoked potentials are of little use in the diagnosis or monitoring of MS: Commentary
|
Hutchinson, Michael
|
|
2013
|
|
14 |
p. 1824-1825
|
artikel
|
| 46 |
Evoked potentials are of little use in the diagnosis or monitoring of MS: No
|
Fernández, Oscar
|
|
2013
|
|
14 |
p. 1822-1823
|
artikel
|
| 47 |
Evoked potentials are of little use in the diagnosis or monitoring of MS: Yes
|
McGuigan, Christopher
|
|
2013
|
|
14 |
p. 1820-1821
|
artikel
|
| 48 |
Exercising away the blues: can it help multiple sclerosis-related depression?
|
Feinstein, Anthony
|
|
2013
|
|
14 |
p. 1815-1819
|
artikel
|
| 49 |
Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients
|
Cavallari, Michele
|
|
2016
|
|
14 |
p. 1841-1849
|
artikel
|
| 50 |
First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm
|
Amarenco, Gérard
|
|
2013
|
|
14 |
p. 1931-1937
|
artikel
|
| 51 |
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
|
Luessi, Felix
|
|
2015
|
|
14 |
p. 1811-1822
|
artikel
|
| 52 |
Gene expression analysis of relapsing–remitting, primary progressive and secondary progressive multiple sclerosis
|
Ratzer, R
|
|
2013
|
|
14 |
p. 1841-1848
|
artikel
|
| 53 |
Gene expression profiling in MS: a fulfilled promise?
|
Baranzini, Sergio E
|
|
2013
|
|
14 |
p. 1813-1814
|
artikel
|
| 54 |
Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors
|
Wang, Yunpeng
|
|
2016
|
|
14 |
p. 1783-1793
|
artikel
|
| 55 |
Genetic risk factors for pediatric-onset multiple sclerosis
|
Gianfrancesco, Milena A
|
|
2018
|
|
14 |
p. 1825-1834
|
artikel
|
| 56 |
Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis
|
Pravatà, Emanuele
|
|
2017
|
|
14 |
p. 1864-1874
|
artikel
|
| 57 |
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study
|
Tinghög, Petter
|
|
2013
|
|
14 |
p. 1923-1930
|
artikel
|
| 58 |
Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: A volumetric and functional connectivity study
|
González Torre, Julio Alberto
|
|
2017
|
|
14 |
p. 1854-1863
|
artikel
|
| 59 |
Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report
|
Shirani, Afsaneh
|
|
|
|
14 |
p. 1937-1941
|
artikel
|
| 60 |
Identical lesion morphology in primary progressive and relapsing–remitting MS –an ultrahigh field MRI study
|
Kuchling, Joseph
|
|
2014
|
|
14 |
p. 1866-1871
|
artikel
|
| 61 |
Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MS
|
Mills, Elizabeth A
|
|
2018
|
|
14 |
p. 1795-1807
|
artikel
|
| 62 |
Impaired retinal microcirculation in multiple sclerosis
|
Jiang, Hong
|
|
2016
|
|
14 |
p. 1812-1820
|
artikel
|
| 63 |
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis
|
Rossi, S
|
|
2014
|
|
14 |
p. 1841-1850
|
artikel
|
| 64 |
Introducing the Barancik Prize lecture series
|
Coetzee, Timothy
|
|
|
|
14 |
p. 1826-1827
|
artikel
|
| 65 |
Investigating multiple sclerosis genetic susceptibility on the founder population of east-central Sardinia via association and linkage analysis of immune-related loci
|
Fazia, Teresa
|
|
2018
|
|
14 |
p. 1815-1824
|
artikel
|
| 66 |
Leptomeningeal enhancement of the spinal cord in sarcoidosis
|
Absinta, Martina
|
|
2018
|
|
14 |
p. 1916-1917
|
artikel
|
| 67 |
Liver injury associated with dimethyl fumarate in multiple sclerosis patients
|
Muñoz, Monica A
|
|
2017
|
|
14 |
p. 1947-1949
|
artikel
|
| 68 |
Longitudinal personality change associated with cognitive decline in multiple sclerosis
|
Roy, Shumita
|
|
2018
|
|
14 |
p. 1909-1912
|
artikel
|
| 69 |
Low JC virus antibody index during natalizumab treatment less safe than assumed?
|
Killestein, Joep
|
|
2015
|
|
14 |
p. 1753-1754
|
artikel
|
| 70 |
Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy
|
Hodel, Jérôme
|
|
2018
|
|
14 |
p. 1902-1908
|
artikel
|
| 71 |
Male factor infertility and risk of multiple sclerosis: A register-based cohort study
|
Glazer, Clara Helene
|
|
2018
|
|
14 |
p. 1835-1842
|
artikel
|
| 72 |
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability
|
Daams, Marita
|
|
2014
|
|
14 |
p. 1860-1865
|
artikel
|
| 73 |
Month-of-birth-effect in multiple sclerosis in Austria
|
Walleczek, Nina-Katharina
|
|
|
|
14 |
p. 1870-1877
|
artikel
|
| 74 |
MS Research Australia Progress in MS Research 2015 Conference 29–30 October, 2015 Melbourne, Australia
|
|
|
2015
|
|
14 |
p. NP1-NP32
|
artikel
|
| 75 |
Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort
|
Johansson, Viktoria
|
|
2014
|
|
14 |
p. 1881-1891
|
artikel
|
| 76 |
Multiple sclerosis in New Zealand Māori
|
Pearson, John F
|
|
2014
|
|
14 |
p. 1892-1895
|
artikel
|
| 77 |
Multiple sclerosis: Progression rate and severity in a multicenter cohort from Algeria
|
Hecham, Nassima
|
|
2014
|
|
14 |
p. 1923-1924
|
artikel
|
| 78 |
Multiple sclerosis, solitary sclerosis or something else?
|
Lattanzi, Simona
|
|
2014
|
|
14 |
p. 1819-1824
|
artikel
|
| 79 |
Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management
|
Shosha, Eslam
|
|
2017
|
|
14 |
p. 1808-1817
|
artikel
|
| 80 |
No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis
|
Campbell, Graham R
|
|
2013
|
|
14 |
p. 1858-1866
|
artikel
|
| 81 |
1 November 2012 - 31 October 2013
|
|
|
2018
|
|
14 |
p. NP1-NP3
|
artikel
|
| 82 |
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial
|
Fox, Edward J
|
|
2018
|
|
14 |
p. 1862-1870
|
artikel
|
| 83 |
Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion
|
London, Frédéric
|
|
|
|
14 |
p. 1888-1895
|
artikel
|
| 84 |
Patient reported outcome measures of upper limb function in multiple sclerosis: A critical overview
|
Lamers, Ilse
|
|
2018
|
|
14 |
p. 1792-1794
|
artikel
|
| 85 |
Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density
|
Mikolajczak, Janine
|
|
2017
|
|
14 |
p. 1847-1853
|
artikel
|
| 86 |
People with MS should consume a low-salt diet – Commentary
|
Pugliatti, Maura
|
|
2016
|
|
14 |
p. 1781-1782
|
artikel
|
| 87 |
People with MS should consume a low-salt diet – NO
|
Ascherio, Alberto
|
|
2016
|
|
14 |
p. 1779-1781
|
artikel
|
| 88 |
People with MS should consume a low-salt diet – YES
|
Farez, Mauricio F
|
|
2016
|
|
14 |
p. 1777-1779
|
artikel
|
| 89 |
Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children
|
Razaz, Neda
|
|
2016
|
|
14 |
p. 1830-1840
|
artikel
|
| 90 |
Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis
|
Oliveira, Luana Michelli
|
|
|
|
14 |
p. 1907-1914
|
artikel
|
| 91 |
Plasma levels of endothelial and B-cell-derived microparticles are restored by fingolimod treatment in multiple sclerosis patients
|
Zinger, Anna
|
|
2016
|
|
14 |
p. 1883-1887
|
artikel
|
| 92 |
Polyunsaturated fatty acids and the risk of multiple sclerosis
|
Bjørnevik, Kjetil
|
|
2017
|
|
14 |
p. 1830-1838
|
artikel
|
| 93 |
Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders
|
Kim, Su-Hyun
|
|
2017
|
|
14 |
p. 1902-1908
|
artikel
|
| 94 |
Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting
|
Rao, Stephen M
|
|
2017
|
|
14 |
p. 1929-1937
|
artikel
|
| 95 |
Progressive cerebral atrophy in neuromyelitis optica
|
Warabi, Yoko
|
|
2015
|
|
14 |
p. 1872-1875
|
artikel
|
| 96 |
Psychiatric comorbidity in multiple sclerosis: It’s not the genes
|
Marrie, Ruth Ann
|
|
2014
|
|
14 |
p. 1803-1805
|
artikel
|
| 97 |
Radiologically isolated syndrome should be treated with disease-modifying therapy – Commentary
|
Lebrun, Christine
|
|
2017
|
|
14 |
p. 1821-1823
|
artikel
|
| 98 |
Radiologically isolated syndrome should be treated with disease-modifying therapy – No
|
Labiano-Fontcuberta, Andrés
|
|
2017
|
|
14 |
p. 1820-1821
|
artikel
|
| 99 |
Radiologically isolated syndrome should be treated with disease-modifying therapy – Yes
|
Okuda, Darin T
|
|
2017
|
|
14 |
p. 1818-1819
|
artikel
|
| 100 |
Regulatory B cells: The key to post-alemtuzumab rebound phenomena in multiple sclerosis?
|
Hardy, Todd A
|
|
|
|
14 |
p. 1945-1946
|
artikel
|
| 101 |
Remyelination and ageing: Reversing the ravages of time
|
Neumann, Bjoern
|
|
|
|
14 |
p. 1835-1841
|
artikel
|
| 102 |
Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis
|
Beauchemin, Philippe
|
|
2016
|
|
14 |
p. 1892-1893
|
artikel
|
| 103 |
Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS
|
Schoonhoven, Deborah N
|
|
|
|
14 |
p. 1896-1906
|
artikel
|
| 104 |
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
|
Oberwahrenbrock, Timm
|
|
2013
|
|
14 |
p. 1887-1895
|
artikel
|
| 105 |
Retinal nerve fibre layer thickness correlates with brain white matter damage in multiple sclerosis: A combined optical coherence tomography and diffusion tensor imaging study
|
Scheel, Michael
|
|
2014
|
|
14 |
p. 1904-1907
|
artikel
|
| 106 |
Retrieval practice is a robust memory aid for memory-impaired patients with MS
|
Sumowski, James F
|
|
2013
|
|
14 |
p. 1943-1946
|
artikel
|
| 107 |
Revised McDonald criteria for multiple sclerosis diagnostics in Central Russia: Sensitivity and specificity
|
Belova, AN
|
|
2014
|
|
14 |
p. 1896-1899
|
artikel
|
| 108 |
Risk factors for falls in multiple sclerosis: an observational study
|
Gunn, Hilary
|
|
2013
|
|
14 |
p. 1913-1922
|
artikel
|
| 109 |
Secondary progressive NMO, or concomitant NMO and a primary neurodegenerative disorder?
|
Rovira, Alex
|
|
2015
|
|
14 |
p. 1876-1878
|
artikel
|
| 110 |
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis
|
Kohlmann, Rebekka
|
|
2015
|
|
14 |
p. 1823-1832
|
artikel
|
| 111 |
Severe B cell–mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis
|
Hyun, Jae-Won
|
|
|
|
14 |
p. 1942-1945
|
artikel
|
| 112 |
Should we systematically test patients with clinically isolated syndrome for auto-antibodies?
|
Negrotto, Laura
|
|
2015
|
|
14 |
p. 1802-1810
|
artikel
|
| 113 |
Sick leave and disability pension before and after diagnosis of multiple sclerosis
|
Landfeldt, Erik
|
|
2016
|
|
14 |
p. 1859-1866
|
artikel
|
| 114 |
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
|
Elliott, Colm
|
|
|
|
14 |
p. 1915-1925
|
artikel
|
| 115 |
Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness
|
Filippatou, Angeliki
|
|
|
|
14 |
p. 1878-1887
|
artikel
|
| 116 |
Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity
|
Chien, Claudia
|
|
|
|
14 |
p. 1926-1936
|
artikel
|
| 117 |
Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results
|
Selmaj, Krzysztof
|
|
2017
|
|
14 |
p. 1909-1917
|
artikel
|
| 118 |
Temperature dependence of multiple sclerosis mortality rates in the United States
|
Sun, Hongbing
|
|
2017
|
|
14 |
p. 1839-1846
|
artikel
|
| 119 |
The best basic science paper in MS in 2013: Antimuscarinic therapies in remyelination
|
Green, Ari J
|
|
2014
|
|
14 |
p. 1814-1816
|
artikel
|
| 120 |
The best basic science paper in multiple sclerosis in 2013: Disease specific molecular events in cortical multiple sclerosis lesions
|
Hutchinson, Michael
|
|
2014
|
|
14 |
p. 1817-1818
|
artikel
|
| 121 |
The central role of mitochondria in axonal degeneration in multiple sclerosis
|
Campbell, Graham R
|
|
2014
|
|
14 |
p. 1806-1813
|
artikel
|
| 122 |
The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy
|
Wattjes, Mike P
|
|
2013
|
|
14 |
p. 1826-1840
|
artikel
|
| 123 |
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): a single case report follow-up study
|
D’Anna, L
|
|
2014
|
|
14 |
p. 1912-1915
|
artikel
|
| 124 |
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): A single case report follow-up study
|
Palavra, Filipe
|
|
2014
|
|
14 |
p. 1916-1917
|
artikel
|
| 125 |
The MSBase registry: Informing clinical practice
|
Kalincik, Tomas
|
|
|
|
14 |
p. 1828-1834
|
artikel
|
| 126 |
The occurrence of dystonia in upper-limb multiple sclerosis tremor
|
Van der Walt, A
|
|
2015
|
|
14 |
p. 1847-1855
|
artikel
|
| 127 |
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses
|
Zandoná, Manuella Edler
|
|
2014
|
|
14 |
p. 1908-1911
|
artikel
|
| 128 |
The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis
|
Koenig, Katherine A
|
|
2015
|
|
14 |
p. 1794-1801
|
artikel
|
| 129 |
The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis
|
Ma, Ashley Y
|
|
2017
|
|
14 |
p. 1884-1892
|
artikel
|
| 130 |
The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study
|
Jonkman, Laura E
|
|
2016
|
|
14 |
p. 1804-1811
|
artikel
|
| 131 |
The use of laboratory gait analysis for understanding gait deterioration in people with multiple sclerosis
|
Cofré Lizama, L Eduardo
|
|
2016
|
|
14 |
p. 1768-1776
|
artikel
|
| 132 |
Time is vision: The importance of the early discovery and diagnosis of optic neuritis
|
Villoslada, Pablo
|
|
2017
|
|
14 |
p. 1806-1807
|
artikel
|
| 133 |
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
|
Cortese, Marianna
|
|
2015
|
|
14 |
p. 1856-1864
|
artikel
|
| 134 |
Tocilizumab, MS, and NMOSD
|
Kleiter, Ingo
|
|
2016
|
|
14 |
p. 1891-1892
|
artikel
|
| 135 |
Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis
|
Sonder, Judith M
|
|
2015
|
|
14 |
p. 1865-1871
|
artikel
|
| 136 |
USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-up
|
Kerbrat, Anne
|
|
2018
|
|
14 |
p. 1852-1861
|
artikel
|
| 137 |
What to make of cannabis and cognition in MS: In search of clarity amidst the haze
|
Feinstein, Anthony
|
|
2015
|
|
14 |
p. 1755-1760
|
artikel
|
| 138 |
Where there is inflammation, treatment may reduce disability progression – Commentary
|
Rube, Jacob
|
|
2018
|
|
14 |
p. 1812-1814
|
artikel
|
| 139 |
Where there is inflammation, treatment may reduce disability progression – No
|
Edan, Gilles
|
|
2018
|
|
14 |
p. 1810-1812
|
artikel
|
| 140 |
Where there is inflammation, treatment may reduce disability progression – Yes
|
Kalincik, Tomas
|
|
2018
|
|
14 |
p. 1808-1810
|
artikel
|
| 141 |
Work status in MS: A proxy measure for comprehensive MS management
|
Playford, ED
|
|
2016
|
|
14 |
p. 1766-1767
|
artikel
|
Tijdschrift beschrijving